ProUroCare Medical Inc. 4/A
4/A · ProUroCare Medical Inc. · Filed Sep 20, 2007
Insider Transaction Report
Form 4/AAmended
Carlson Richard Craig
DirectorCEO
Transactions
- Purchase
Common Stock, $.00001 par value
2007-09-10$0.30/sh+8,500$2,550→ 8,500 total
Holdings
- 150,000
Stock Options
Exercise: $2.35Exp: 2015-01-03→ Common Stock, $.00001 par value (150,000 underlying) - 50,000
Stock Options
Exercise: $0.75Exp: 2011-03-02→ Common Stock, $.00001 par value (50,000 underlying) - 200,000
Stock Options
Exercise: $0.05Exp: 2014-02-01→ Common Stock, $.00001 par value (200,000 underlying)
Footnotes (4)
- [F1]133,344 shares vested and exercisable as of September 12, 2007; remainder vest as to 4,167 shares per month through January 1, 2008.
- [F2]The Options shall vest on the date the Commpany is cleared by the FDA to sell the ProUroScan system in the United States.
- [F3]The Option shall vest as enumerated: (a) 50,000 shares are vested and exerciasable as of September 12, 2007;(b)50,000 shares vest, upon the Company's closing on new equity financing arrangements aggregating to $3,000,000 or more after February 1, 2007 and prior to December 31, 2007;(c) 50,000 shares, if the Company records gross product revenues of $1,000,000 or more in the Company's 2008 fiscal year; and(d) 50,000 shares vest on December 31, 2008.
- [F4]This amendment is to correct the number of shares purchased to 8,5000 shares from the previously reported 2,500 shares. No other changes were made made from the previous filing.